In other countries
The same active substances on other registers, the same brand first.
- ETOSUXIMIDA FAES 250 mg CAPSULAS DURASSpain · 250 mg · cápsula dura · Faes Farma S.A.Same form
- Suxital 250 mg meke kapsuleCroatia · Kapsula, meka · Makpharm d.o.o., Trnjanska cesta 37/1, Zagreb, HrvatskaSame form
- ZarontinItaly · Capsula molle · Essential Pharma (M) LTDSame form
- Ethosuximide Strides 250 mg zachte capsulesNetherlands · Capsule, zacht · Strides Pharma (Cyprus) LimitedSame form
- Ethymal 250 mg, capsules, zachtNetherlands · Capsule, zacht · Aurobindo Pharma B.V.Same form
- ZarontinNew Zealand · Cap 250 mgSame form
- PETINIMID 250 mgRomania · 250mg · caps. moi · Lannacher Heilmittel Ges.M.B.H.Same form
- Petinimid Caps MoiRomania · 250mg · caps. moi · Gerot Pharmazeutika GMBHSame form
- Zarontin Cap 250MGSaudi Arabia · Park-DavisSame form
- EthosuximideUnited States · 250MG · capsule · Puracap Pharm LLCSame form
- ZarontinUnited States · 250MG · capsule · Parke DavisSame form
- EtoxinBrazil · Apsen Farmaceutica S/ASame substance
- Etosuccimide GlenmarkItaly · Soluzione orale · Glenmark Arzneimittel GMBHSame substance
- ZarontinItaly · Sciroppo · New Pharmashop S.R.L.Same substance
- Ethymal 250 mg/4 ml, siroopNetherlands · Stroop · Aurobindo Pharma B.V.Same substance
- ZarontinNew Zealand · Oral liq 50 mg per mlSame substance
- ZarontinNew Zealand · Oral liq 250 mg per 5 mlSame substance
- Suxinutin®Serbia · 250mg/5mL · sirup · Clinres Farmacija D.O.O. BeogradSame substance
- Zarontin Syr 250MG-5MLSaudi Arabia · Park-DavisSame substance
- EthosuximideUnited States · 250MG/5ML · syrup · Chartwell RXSame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Ethosuximide
- Strength
- 250 MG
- Dosage form
- Capsule
- Route
- Oral
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 19 Jun 2024
- Registration
- DIN 02545772
- Marketing authorisation holder
- Marcan Pharmaceuticals INC
- ATC code
- N03AD01
- Group
- Nervous system
- Supply
- PRESCRIPTION